Table 1.
Comparison of main sociodemographic features and tobacco consumption variables among non users vs. users of any ICT
| Total | Non users | Users | P -value | ||||
|---|---|---|---|---|---|---|---|
| N | (%) | N | (%) | N | (%) | ||
| Participants | 1725 | 269 | (15.6) | 1456 | (84.4) | ||
| Gender | 1725 | <0.001 | |||||
| Male | 865 | (51.1) | 180 | (33.1) | 685 | (53.0) | |
| Female | 860 | (49.9) | 89 | (66.9) | 771 | (47.0) | |
| Age (years). Mean (SD). | 45.54 (13.65) | 55,60 (11.97) | 41,39 (12.06) | <0.001 | |||
| Age group | 1725 | <0.001 | |||||
| 18-35 | 451 | (26.1) | 6 | (2.2) | 445 | (30.6) | |
| 36-45 | 402 | (23.3) | 21 | (7.8) | 381 | (26.2) | |
| 46-65 | 733 | (42.5) | 159 | (59.1) | 574 | (39.4) | |
| >65 | 139 | (8.1) | 83 | (30.9) | 56 | (3.8) | |
| Marital status | 1725 | <0.001 | |||||
| Married | 1096 | (63.5) | 198 | (73.6) | 898 | (61.7) | |
| Single | 395 | (22.9) | 27 | (10.0) | 368 | (25.3) | |
| Separate | 174 | (10.1) | 18 | (6.7) | 156 | (10.7) | |
| Widow/er | 60 | (3.5) | 26 | (9.7) | 34 | (2.3) | |
| Social class | 1658 | <0.001 | |||||
| Most favored: Non-manual | 672 | (40.5) | 40 | (16.5) | 632 | (44.7) | |
| Disadvantaged: Manual | 986 | (59.5) | 203 | (83.5) | 783 | (55.3) | |
| Educational level | 1723 | <0.001 | |||||
| Lower secondary education | 819 | (47.5) | 216 | (80.3) | 603 | (41.5) | |
| Secondary/higher education | 904 | (52.5) | 53 | (19.7) | 851 | (58.5) | |
| Number cigarettes/day. Mean (SD). | 15.39 (9.28) | 17.35 (11.40) | 15.03 (8.80) | <0.001 | |||
| Age of initiation consumption. Mean (SD). Mean (SD) MEAN | 17.21 (4.55) | 18.62 (6.64) | 16.96 (4.01) | <0.001 | |||
| Fagerström test. Mean (SD) | 2.35 (1.63) | 2.62 (1.74) | 2.31 (1.61) | 0.004 | |||
| Fagerström test | 1693 | <0.001 | |||||
| Low | 862 | (50.9) | 130 | (48.9) | 732 | (51.3) | |
| Medium | 691 | (40.8) | 98 | (36.8) | 593 | (41.6) | |
| High | 140 | (8.3) | 38 | (14.3) | 102 | (7.1) | |
| Attempts at smoking cessation. Mean (SD). | 2.2 (2.4) | 2.1 (2.2) | 2.2 (2.5) | 0.480 | |||
| Smoking environment of partner* | 1448 | <0.001 | |||||
| Yes | 695 | (47.9) | 69 | (31.7) | 626 | (50.9) | |
| No | 753 | (52.1) | 149 | (68.3) | 604 | (49.1) | |
| Presence of smoking in the home* | 1673 | 0.001 | |||||
| Yes | 939 | (87.5) | 121 | (47.1) | 818 | (57.8) | |
| No | 734 | (12.5) | 136 | (52.9) | 598 | (42.2) | |
| Workplace/smoking studies* | 1351 | 0.970 | |||||
| Yes | 745 | (55.2) | 73 | (55.3) | 672 | (55.1) | |
| No | 606 | (44.8) | 59 | (44.7) | 547 | (44.9) | |
| Smoking environment of friends | 1725 | 0.570 | |||||
| Yes | 1129 | (65.4) | 172 | (63.9) | 957 | (65.7) | |
| No | 596 | (34.6) | 97 | (36.1) | 499 | (34.3) | |
| Have made some attempt to quit smoking | 1582 | 0.830 | |||||
| Yes | 1179 | (74.5) | 349 | (74.9) | 830 | (74.4) | |
| No | 403 | (25.5) | 117 | (25.1) | 286 | (25.6) | |
| Pharmacoterapy used for smoking cessation† | 1137 | 0.210 | |||||
| Nicotine replacement therapy | 132 | (11.6) | 17 | (9.7) | 115 | (12.0) | |
| Bupropion | 27 | (2.4) | 5 | (2.8) | 22 | (2.3) | |
| Varenicline | 43 | (3.8) | 4 | (2.3) | 39 | (4.1) | |
| ≥2 treatments | 64 | (5.6) | 5 | (2.8) | 59 | (6.1) | |
| No medication | 871 | (76.6) | 145 | (82.4) | 726 | (75.5) | |
| Chronic medication intake | 1137 | 0.049 | |||||
| Some medication | 266 | (23.4) | 31 | (17.6) | 235 | (24.5) | |
| No medication | 871 | (76.6) | 145 | (82.4) | 726 | (75.5) | |
SD: Standard deviation.
P-value derived from the Chi-square test and ANOVA in categorical and continuous variables, respectively.
*Not taking into account cases of “not applicable”:without partner, living alone or not working or studying.
†In the last attempt to quit.
P-value derived from the Chi-square test and ANOVA in categorical and continuous variables, respectively.